These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1697660

  • 21. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature.
    Ghigo E, Mazza E, Imperiale E, Rizzi G, Benso L, Müller EE, Camanni F, Massara F.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):452-6. PubMed ID: 3114300
    [Abstract] [Full Text] [Related]

  • 22. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
    Giusti M, Marini G, Sessarego P, Peluffo F, Valenti S, Caratti C, Giordano G.
    Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302
    [Abstract] [Full Text] [Related]

  • 23. Methionine potentiates both basal and GHRH-induced GH secretion in children.
    Bellone J, Farello G, Bartolotta E, Aimaretti G, Bellone S, Mucci M, De Matteis F, Ghigo E.
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):61-4. PubMed ID: 9302373
    [Abstract] [Full Text] [Related]

  • 24. Modulation of growth hormone-releasing activity of hexarelin in man.
    Arvat E, Gianotti L, Di Vito L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E.
    Neuroendocrinology; 1995 Jan; 61(1):51-6. PubMed ID: 7731498
    [Abstract] [Full Text] [Related]

  • 25. Effect of galanin and arginine, alone or in combination, on growth hormone secretion in adult patients treated with glucocorticoids.
    Giustina A, Licini M, Girelli A, Bussi AR, Wehrenberg WB.
    Neuroendocrinology; 1993 May; 57(5):843-8. PubMed ID: 7692338
    [Abstract] [Full Text] [Related]

  • 26. Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications.
    Müller EE, Locatelli V, Ghigo E, Cella SG, Loche S, Pintor C, Camanni F.
    Drugs; 1991 Feb; 41(2):161-77. PubMed ID: 1709847
    [Abstract] [Full Text] [Related]

  • 27. Intranasal administration of neostigmine potentiates both intravenous and intranasal growth hormone (GH)-releasing hormone-induced GH release in short children.
    Ghigo E, Procopio M, Bellone J, Mazza E, Mucci M, Boghen MF, Müller EE, Camanni F.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):467-70. PubMed ID: 1991816
    [Abstract] [Full Text] [Related]

  • 28. Pretreatment with somatostatin analog SMS 201-995 potentiates growth hormone (GH) responsiveness to GH-releasing factor in short children.
    Dickerman Z, Guyda H, Tannenbaum GS.
    J Clin Endocrinol Metab; 1993 Sep; 77(3):652-7. PubMed ID: 8257527
    [Abstract] [Full Text] [Related]

  • 29. Comparative effect of galanin and pyridostigmine on the growth hormone response to growth hormone-releasing hormone in normal aged subjects.
    Giustina A, Bussi AR, Conti C, Doga M, Legati F, Macca C, Zuccato F, Wehrenberg WB.
    Horm Res; 1992 Sep; 37(4-5):165-70. PubMed ID: 1283383
    [Abstract] [Full Text] [Related]

  • 30. The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese children.
    Loche S, Pintus S, Cella SG, Boghen M, Vannelli S, Benso L, Müller EE, Corda R, Pintor C.
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):187-92. PubMed ID: 1699689
    [Abstract] [Full Text] [Related]

  • 31. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects.
    Peñalva A, Muruais C, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1990 Feb; 70(2):324-7. PubMed ID: 2105328
    [Abstract] [Full Text] [Related]

  • 32. Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man.
    Cappa M, Grossi A, Benedetti S, Drago F, Loche S, Ghigo E.
    J Endocrinol Invest; 1993 Jun; 16(6):421-4. PubMed ID: 8370917
    [Abstract] [Full Text] [Related]

  • 33. Acute administration of pyridostigmine and clonidine has an additive stimulatory effect on GH release in normal children.
    Ghigo E, Goffi S, Mazza E, Imperiale E, Arvat E, Bellone J, Procopio M, Müller EE, Camanni F.
    J Endocrinol Invest; 1989 Feb; 12(2):99-101. PubMed ID: 2754188
    [Abstract] [Full Text] [Related]

  • 34. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.
    Page MD, Dieguez C, Valcavi R, Edwards C, Hall R, Scanlon MF.
    Clin Endocrinol (Oxf); 1988 May; 28(5):551-8. PubMed ID: 3145820
    [Abstract] [Full Text] [Related]

  • 35. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
    Ghigo E, Goffi S, Nicolosi M, Arvat E, Valente F, Mazza E, Ghigo MC, Camanni F.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
    Pihoker C, Middleton R, Reynolds GA, Bowers CY, Badger TM.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
    [Abstract] [Full Text] [Related]

  • 37. Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome.
    Cappa M, Grossi A, Borrelli P, Ghigo E, Bellone J, Benedetti S, Carta D, Loche S.
    Horm Res; 1993 Oct; 39(1-2):51-5. PubMed ID: 8406340
    [Abstract] [Full Text] [Related]

  • 38. Cholinergic enhancement of pyridostigmine potentiates spontaneous diurnal but not nocturnal growth hormone secretion in short children.
    Ghigo E, Imperiale E, Mazza E, Goffi S, Procopio M, Müller EE, Camanni F.
    Neuroendocrinology; 1989 Feb; 49(2):134-7. PubMed ID: 2498754
    [Abstract] [Full Text] [Related]

  • 39. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    Peino R, Cordido F, Peñalva A, Alvarez CV, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549
    [Abstract] [Full Text] [Related]

  • 40. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
    Valcavi R, Valente F, Dieguez C, Zini M, Procopio M, Portioli I, Ghigo E.
    J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.